To provide for expedited consideration by the Supreme Court of certain actions challenging the constitutionality of certain provisions of the Patient Protection and Affordable Care Act.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
59pct
11d open
vs 6,662 other HR bills in the 112th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $914,888 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
Client expense: $902,453 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); HR 2077 S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR a839 (Antitrust exemption for commurnity pharmacists); S. 1058/HR 1971 (forced disclosure of PBM proprietary pricing and other competitive information). HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA Annual insurer fee).
Client expense: $1,009,998 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of, White House Office
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out ACA provisions per state-passed legislation); HR 2077 (MLR repeal) S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill). HR 1839 (Antitrust exemption for community pharmacists); S. 1058/HR 1971 (Forced disclosure of PBM proprietary pricing and other competitive information); HR 371 (Health Choice Act); HR 2011 (Repeal MLR); HR 1370 (Repeal ACA annual fee in insurers)
Client expense: $902,453 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2011 · first_quarter · Health Issues
H.R. 2 -- Repealing the Job-Killing Health Care Law Act S.582: Social Security Protection Act of 2011 H.R.1010: H.R.3590:Patient Protection and Affordable Care Act HR 1010 Challenging the constitutionality of any provision of the Patient Protection and Affordable Care Act
Client expense: $1,731,351 · Firm income: Not reported
Government targets: Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, Treasury, Dept of, White House Office
HR 2 (repeal ACA); HR 2 (De-fund ACA); HR 1010 (directs SCOTUS to expedite appeal on Constitutionality of ACA); H. Res. 9 (Instructs Committees to develop proposals as alternatives to ACA); HR 4 (repeal 1099 provision of ACA); HR 21/S. 19 (repeal ACA's individual mandate); H. J. Res 19 (Expression of disapproval of HHS Regulation on MLR); HR 1206 (Exclude broker remuneration from MLR); S. 244 ( allows states to opt out of enumerated ACA provisions per state-passed legislation); S. 248 (accelerates from 2017 to 2014 the right of states to seek federal waiver from specified provisions of ACA); S. 312/HR 605 (repeals ACA provision barring use of FSA/HSA money for OTC medications); HR 1150 (amends McCarran-Ferguson); HR 979 (imposes new requirements on PBMs and insurers who participate in FEHBP); S. 27 (prohibits settlement of patent infringement cases which results in delay of generics coming to market); S. 493 (Small Business bill).
Client expense: $1,083,703 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE